Home › Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...
 

Keywords :   


Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...

2014-05-12 06:00:00| Industrial Newsroom - All News for Today

AUSTIN, Texas - Luminex Corporation (NASDAQ: LMNX) today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES&trade;. The assay will complement Luminex's growing portfolio of ASR and IVD products. Previously announced items in the five assay launch menu targeted for the ARIES system include: Flu A/B and RSV, HSV 1&2, Norovirus, and Clostridium difficile (C. diff).<br /> <br /> "ARIES represents the ...This story is related to the following:Test and Measuring InstrumentsSample Conditioning Equipment | Laboratory Equipment & Supplies

Tags: for new its group

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »